作者
Marcel Schneider,Jeesun Kim,Felix Berlth,Yutaka Sugita,Peter Grimminger,Bas P. L. Wijnhoven,Hidde C.G. Overtoom,Ines Gockel,René Thieme,Ewen A. Griffiths,William Butterworth,Henrik Nienhüser,Beat Müller,Nerma Crnovrsanin,Dániel Gerö,Felix Nickel,Suzanne S. Gisbertz,Mark I. van Berge Henegouwen,Philip H. Pucher,Kashuf Khan,Asif Chaudry,Pranav Patel,Manuel Pera,Mariagiulia Dal Cero,Carlos Garcı́a,G.E. Salinas,P Kassab,Osvaldo Antônio Prado Castro,Enrique Norero,Paul Wisniowski,Luke R. Putnam,Pietro Maria Lombardi,Giovanni Ferrari,Rita Gudaitytė,Almantas Maleckas,Leanne Prodehl,Antonio Castaldi,Michel Prudhomme,Hyukjoon Lee,Takeshi Sano,Gian Luca Baiocchi,Giovanni De Manzoni,Simone Giacopuzzi,Maria Bencivenga,Riccardo Rosati,Francesco Puccetti,Domenico D’Ugo,Souya Nunobe,Han Kwang Yang,Christian A. Gutschow
摘要
Objective/Background: Various anastomotic and reconstruction techniques are used for minimally invasive total (miTG) and distal gastrectomy (miDG). Their effects on postoperative morbidity have not been extensively studied. Methods: MiTG and miDG patients were selected from 9356 oncological gastrectomies performed 2017-2021 in 44 centers. Endpoints included anastomotic leakage (AL) rate and postoperative morbidity tested by multivariable analysis. Results: Three major anastomotic techniques (circular stapled (CS); linear stapled (LS); hand sewn (HS)), and three major bowel reconstruction types (Roux (RX); Billroth I (BI); Billroth II (BII)) were identified in miTG (n=878) and miDG (n=3334). Postoperative complications including AL (5.2% vs. 1.1%), overall (28.7% vs. 16.3%) and major morbidity (15.7% vs. 8.2%), as well as 90-day mortality (1.6% vs. 0.5%) were higher after miTG compared with miDG. After miTG, AL rate was higher after CS (4.3%) and HS (7.9%) compared with LS (3.4%). Similarly, major complications (LS: 9.7%, CS: 16.2%, HS: 12.7%) were lowest after LS. Multivariate analysis confirmed anastomotic technique as predictive factor for AL, overall and major complications. In miDG, AL rate (BI: 1.4%, BII 0.8%, RX 1.2%), overall (BI: 14.5%, BII: 15.0%, RX: 18.7%,) and major morbidity (BI: 7.9%, BII: 9.1%, RX: 7.2%), and mortality (BI: 0%, BII: 0.1%, RY: 1.1%%) were not affected by bowel reconstruction. Conclusion: In oncologically suitable situations, miDG should be preferred to miTG, as postoperative morbidity is significantly lower. LS should be a preferred anastomotic technique for miTG in Western Centers. Conversely, bowel reconstruction in DG may be chosen according to surgeon’s preference.